# OnCo record relay-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/relay-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "relay-therapeutics" ;
  schema:name "Relay Therapeutics"@en ;
  schema:description "Relay Therapeutics uses computer simulations of how proteins move to design precise cancer pills. Its lead drug, zovegalisib, targets a mutated growth protein called PI3K-alpha in breast cancer while sparing the normal version."@en ;
  schema:url <https://onco.cc/companies/relay-therapeutics/>, <https://relaytx.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://relaytx.com/>, <https://relaytx.com/pipeline/>, <https://www.sec.gov/Archives/edgar/data/1812364/000119312520194016/d904779d424b4.htm> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/cholangiocarcinoma/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/>, <https://onco.cc/technologies/ai-drug-design/> ;
  onco:targets <https://onco.cc/targets/pik3ca/>, <https://onco.cc/targets/fgfr2/> ;
  onco:drugs <https://onco.cc/drugs/zovegalisib/> .